Following the idea of incorporating drugs onto the stent surface, several substances have already been used in DESs.
Milestones.
D5. Report on Drugs assessed for DESs to reduce the urinary stents's morbidity, including scientific papers and TS, meetings, WkS and STSM related to the WG5 of the Action (M44).
Leader: Gianluca Ciardelli
Vice-Leader: Syed Tofail
COST is supported by the EU
Framework Programme Horizon 2020.
COST Association
Avenue Lousie 149 | 1050 Brussels, Belgium
info@enius.org
Tel: +32 (0)2 533 3800 | Fax: Fax: +32 (0)2 533 3890
Email usEuropean Network of Multidisciplinary Research to Improve the Urinary Stents (ENIUS)
